Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Moxifloxacin Punctum Plug for Sustained Drug Delivery
2011
Breast-cancer detection using blood-based infrared molecular fingerprints
2021 StandoutNobel
Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis
2002 Standout
Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review
2017
Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy
2017
Clinical Significance of Nephrotoxicity in Patients Treated with Amphotericin B for Suspected or Proven Aspergillosis
1999
Natural products: A continuing source of novel drug leads
2013 Standout
Adverse Drug Reactions to Systemic Antifungals Prevention and Management
1992
Current Options in Antifungal Pharmacotherapy
2008
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils
2003
Spleen deposition ofCryptococcus neoformanscapsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1
2008 StandoutNobel
Monoclonal antibody based ELISAs for cryptococcal polysaccharide
1992
The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism
2008
A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia
2000
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Antifungal Agents. Part I. Amphotericin B Preparations and Flucytosine
1998
Amphotericin B Use in a Community Hospital, with Special Emphasis on Side Effects
1998
Amphotericin B: 30 Years of Clinical Experience
1990
Topographic diversity of fungal and bacterial communities in human skin
2013 StandoutNature
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Cryptococcal capsular polysaccharide clearance in nonimmune mice
1982
Zygomycetes in Human Disease
2000 Standout
Comparison of the PREMIER cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens
1991
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Serology of Human Cryptococcosis
1968
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis
1993
THE TREATMENT OF COCCIDIOIDAL MENINGITIS. THE USE OF AMPHOTERICIN B IN A GROUP OF 25 PATIENTS.
1964
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
Clinical Prediction Rules for Children: A Systematic Review
2011
Nocardia species: host-parasite relationships
1994 Standout
Cataracts
2017 Standout
Opportunistic Pulmonary Infections
1966
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Serologic Tests in Diagnosis and Prognosis of Cryptococcosis
1966
The Compromised Host and Infection. II. Deep Fungal Infection
1969 Standout
Racial Disparities in Pain Management of Children With Appendicitis in Emergency Departments
2015
Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites
2016 Standout
Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity
1991
Variant Forms of Pulmonary Cryptococcosis
1968
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Works of Jonathan E. Bennett being referenced
Effect of Hispanic Ethnicity and Language Barriers on Appendiceal Perforation Rates and Imaging in Children
2014
Assessing the Benefit of Radiation Therapy After Breast-Conserving Surgery for Ductal Carcinoma-In-Situ
2005
DETECTION OF CRYPTOCOCCAL POLYSACCHARIDE IN SERUM AND SPINAL FLUID: VALUE IN DIAGNOSIS AND PROGNOSIS.
1964
Clinical Features of Bacterial Conjunctivitis in Children
2007
Reducing amphotericin B reactions. A double-blind study.
1963
Parents' utilities for outcomes of occult bacteremia.
2000